1) Melin A, Sparen P, Persson I, et al : Endometriosis and the risk of cancer with special emphasis on ovarian cancer. Hum Reprod 21 : 1237─1242, 2006
2) Brinton LA, Lamb EJ, Moghissi KS, et al : Ovarian cancer risk associated with varying causes of infertility. Fertil Steril 82 : 405─416, 2004
3) Sampson J : Endometrial carcinoma of the ovary. Arising in endometrial tissue in that organ. Arch Surg 10 : 1─72, 1925
4) Scott RB : Malignant changes in endometriosis. Obstet Gynecol 2 : 283─289, 1953
5) Corner GW Jr, Hu CY, Hertig AT : Ovarian carcinoma arising in endometriosis. Am J Obstet Gynecol 9 : 760─774, 1950
6) Scully RE, Richardson GS, Barlow JF : The development of malignancy in endometriosis. Clin Obstet Gynecol 9 : 381─414, 1966
7) Nishida M, Watanabe K, Sato N, et al : Malignant transformation of ovarian endometriosis. Gynecol Obstet Invest 50 : 18─25, 2000
8) Prefumo F, Todeschini F, Fulcheri E, et al : Epithelial abnormalities in cystic ovarian endometriosis. Gynecol Oncol 84 : 280─284, 2002
9) Yoshikawa H, Jimbo H, Okada S, et al : Prevalence of endometriosis in ovarian cancer. Gynecol Obstet Invest 50 : 11─17, 2000
10) Fukunaga M, Nomura K, Ishikawa E, et al : Ovarian atypical endometriosis : its close association with malignant epithelial tumors. Histopathology 30 : 249─255, 1997
11) Vigano P, Somigliana E, Chiodo I, et al : Molecular mechanisms and biological plausibility underlying the malignant transformation of endometriosis : a critical analysis. Hum Reprod 12 : 77─89, 2006
12) Mutter GL, Lin MC, Fitzgerald JT, et al : Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers. J Nathl Cancer Inst 92 : 924─930, 2000
13) Dinulescu DM, Ince TA, Quade BJ, et al : Role of Kras and PTEN in the development of mouse models of endometriosis and endometrioid ovarian cancer. Nat Med 11 : 63─70, 2005
14) Kobayashi H, Sumimoto K, Moniwa N, et al : Risk of developing ovarian cancer among women with ovarian endometrioma : a cohort study in Shizuoka, Japan. Int J Gynecol Cancer 17 : 37─43, 2007
15) Rulin MC, Preston AL : Adnexal masses in postmenopausal women. Obstet Gynecol 70 : 578─581, 1987
16) 島田宗昭,大石徹郎,金森康展,他 : 卵巣チョコレート嚢胞から悪性腫瘍除外診断の試み.日本婦人科腫瘍学会誌23 : 67─71,2005
17) Tagashira Y, Shimada M, Kigawa J, et al : Ovarian endometrioid adenocarcinoma arising from endometriosis in a young woman. Gynecol Oncol 91 : 643─647, 2003
18) Bast RC Jr, Feeney M, Lazarus H, et al : Reactivity of monoclonal antibody with human ovarian carcinoma. J Clin Invest 68 : 1331─1337, 1981
19) Mol BW, Bayram N, Lijmer JG, et al : The performance of CA125 measurement in the detection of endometriosis : a meta─analysis. Fertil Steril 70 : 1101─1108, 1998
20) Chen FP, Soong YK, Lee N, et al : The use of serum CA─125 as a marker for endometriosis in patients with dysmenorrheal for monitoring therapy and for recurrence of endometriosis. Acta Obstet Gynecol Scand 77 : 665─670, 1998
21) Malkasian GD Jr, Knapp RC, Lavin PT, et al : Preoperative evaluation of serum CA125 levels in premenopausal and postmenopausal patients with pelvic masses : discrimination of benign from malignant disease. Am J Obstet Gynecol 159 : 341─346, 1988
22) Johansson J, Santala M, Kauppila A : Explosive rise of serum CA125 following the rupture of ovarian endometrioma. Hum Reprod 13 : 3503─3504, 1998
23) 日本産科婦人科学会(編) : 子宮内膜症取扱い規約.第2部 治療編・診断編,第1版.金原出版,pp3─4,2004
24) Winter WE 3rd, Maxwell GL, Tian C, et al : Prognostic factors for stage III epithelial ovarian cancer : a Gynecologic Oncology Group Study. J Clin Oncol 25 : 3621─3627, 2007